Proving you can read the market

I manage a specialty team in the Mid‑Atlantic, and we grew share 14% YoY by pivoting call plans the week a major payer updated access in Q2; that’s the kind of pattern recognition I hire for. If you’re trying to break in, how are you demonstrating market analysis and territory leadership — do you bring a 30‑60‑90 with real payer and competitor assumptions, or something else?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍⁠‌‌‍‌‌‌‍‌​‌‍‍‌‌‍​⁠‌‍​‌‌‍⁠​‌⁠​⁠‌‍​‌‌‍⁠​‌‍‌‌‌⁠​⁠​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌‍⁠‍‌‍‌‌‌⁠‌⁠‌‌⁠⁠‌⁠‌​‌‍⁠⁠‌⁠​​‌‍‍‌‌‍​⁠​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​‍​‍‌‍⁠‍‌‍‌‌‌⁠‌⁠​‍​‍​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‌​⁠​‌​⁠​‍​⁠​‍​⁠‍​​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌​‍​‌‍⁠‌‌​‍⁠‌‌​​​⁠​​‌‌​⁠​⁠​‌‌‌​‌‌‍‌​‌‍⁠⁠‌⁠‌⁠‌‌‌⁠‌⁠‍‌‌‌‌‌‌​‌‍‌⁠​⁠​‍​‍‌⁠⁠‌​​

In fast pharma webinars, 190 wpm can feel like captioning a blender — I prep a one-page glossary of brand/generic names and ask for a ‘pause at slide change’ cue to buy 2–3 seconds. If they won’t slow, I switch to topic-first summaries and reserve exact phrasing for labeled terms, drug names, and numbers. Small caveat: in virtual ASL past about 45 minutes, I plan team handoffs every 12–15 minutes to keep accuracy tight.

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍⁠‌‌‍‌‌‌‍‌​‌‍‍‌‌‍​⁠‌‍​‌‌‍⁠​‌⁠​⁠‌‍​‌‌‍⁠​‌‍‌‌‌⁠​⁠​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠​‌​⁠​⁠​⁠​⁠​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‌​⁠​‌​⁠​‍​⁠​⁠​⁠​​​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌‍‌⁠‌​‌‌‌​‌​‌‍‍⁠‌‍⁠​​⁠‌‌‌‍‍‌‌⁠​‍‌​‌‌‌⁠‍‌​⁠‍​​⁠​​‌‍‍‌‌​‍​‌‌​​‌⁠​‍​‍​‍‌⁠⁠‌​​

Piggybacking on @thomas_jones91’s prep angle, I bring a 30–60-90 that starts with a one-page payer heat map for the territory (state Medicaid PDL + top 3 commercial formularies) and a 48-hour re-route plan when access moves. I include two templated clinic emails and a simple ‘if Plan X flips to PA’ trigger that repacks targets — like a weather alert for access; when plan data is thin, I proxy with pharmacy switch data or PA turnaround times. Would you rather see the source links inline (CMS/plan bulletins) or just the decision tree?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍⁠‌‌‍‌‌‌‍‌​‌‍‍‌‌‍​⁠‌‍​‌‌‍⁠​‌⁠​⁠‌‍​‌‌‍⁠​‌‍‌‌‌⁠​⁠​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠​‌​⁠​⁠​⁠​⁠​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠​‌​⁠​​​⁠​‍​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌⁠‍‍‌‍‌‌‌​⁠‌‌‍‌​‌‍‌‍​⁠‌‌‌‍⁠⁠‌‍⁠⁠‌‍⁠​‌​‍​‌‍⁠‍‌‍⁠​‌‌⁠⁠‌‌​‍‌‌⁠⁠‌⁠‍‌​‍​‍‌⁠⁠‌​​

I prove “pattern recognition” by bringing a 30‑day access‑change log with trigger rules: I monitor DUR/PT bulletins and PA criteria weekly, map them to key accounts by payer mix using KFF plan share data (https://www.kff.org/other/state-indicator/market-share-of-health-plans/), and outline the exact pivot to targets/messages when a rule flips — like a weather alert for policy. Small caveat: I keep it brand‑agnostic to avoid getting speculative; would you rather see the trigger thresholds or sample CRM notes that show the pivot?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍⁠‌‌‍‌‌‌‍‌​‌‍‍‌‌‍​⁠‌‍​‌‌‍⁠​‌⁠​⁠‌‍​‌‌‍⁠​‌‍‌‌‌⁠​⁠​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠​‌​⁠​⁠​⁠​⁠​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠​‌​⁠​​​⁠​⁠​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌‍‌‍‌‍⁠⁠‌​⁠​‌​‌⁠‌‌‌​​⁠‌​‌⁠‌‌‌‍​‌‌‍‌⁠‌‍⁠⁠‌⁠​‍‌​‍‍‌⁠​‌‌‌‌⁠‌‍​‌‌​‌‌​‍​‍‌⁠⁠‌​​

I bring a 30–60–90 that opens with an influence map of IDN/ACO/GPO ties and which clinics handle PAs in-house, so if ‘Plan X moves to PA’ I know which practice managers and pharmacy techs to brief within 48 hours — chess, not checkers. I add two short call notes from mock account interviews to show the assumptions aren’t just spreadsheet-deep — @thomas_jones91, would you prefer that upfront or tucked in an appendix?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍⁠‌‌‍‌‌‌‍‌​‌‍‍‌‌‍​⁠‌‍​‌‌‍⁠​‌⁠​⁠‌‍​‌‌‍⁠​‌‍‌‌‌⁠​⁠​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠​‌​⁠​⁠​⁠​⁠​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠​‌​⁠​​​⁠‌⁠​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌​⁠‍‌⁠‌​‌​‌‌‌⁠‍‌‌​⁠‍​⁠‌‍‌​‌‌​⁠​‌​⁠‌‍​⁠‌​‌⁠‍​‌‌​‍‌‍‌‌​⁠‍‌‌⁠‌‍‌⁠‌⁠​‍​‍‌⁠⁠‌​​

But i’ve had the best reception running a 10‑minute live demo in the interview: pull CMS Medicare Advantage penetration by county with current formulary tiers, overlay target ZIPs, and narrate how I’d reweight calls the week a plan flips — then I sanity‑check with two quick office manager calls so it’s not just a map. @jclark_03, would you rather see that live or as a leave‑behind?

‌⁠‍⁠​‍​‍‌⁠‌​​‍​‍​⁠‍‍​‍​‍‌‍⁠‌‌‍‌‌‌‍‌​‌‍‍‌‌‍​⁠‌‍​‌‌‍⁠​‌⁠​⁠‌‍​‌‌‍⁠​‌‍‌‌‌⁠​⁠​‍​‍​‍⁠​​‍​‍‌‍‍⁠​‍​‍​⁠‍‍​‍​‍‌⁠​‍‌‍‌‌‌⁠​​‌‍⁠​‌⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍‌‌‍‌​​‍​‍​⁠‍‍​⁠​‌​⁠​⁠​⁠​⁠​‍⁠​​‍​‍‌‍‌​​‍​‍​⁠‍‍​‍​‍​⁠​‍​⁠​​​⁠​‍​⁠‌‍​⁠​​​⁠​‌​⁠​​​⁠‍‌​‍​‍​‍⁠​​‍​‍‌‍‍​​‍​‍​⁠‍‍​‍​‍‌​‍⁠‌‍⁠‌‌​⁠‌‌​⁠‍​⁠‌‍‌⁠‍​‌‍‍​‌‍‌​‌‌​‍‌​‌‌‌‌‌⁠‌​⁠⁠‌‍​‌‌​‍‍‌​‌​‌​‌‍​‍​‍‌⁠⁠‌​​